Coverage: Medicaid coverage policies for GLP-1 medications were obtained from KFF.org
According to Holst this result was especially encouraging
The Jastreboff Phase 2 trial randomised 338 adults with body mass index 30 (or 27 with at least one weight-related condition) to retatrutide 1, 4, 8, or 12 mg subcutaneously once weekly, or placebo, for 48 weeks
This Week in GLP-1: A $149 Pill, Wegovy HD, and Canadian Generic Delays Advertisement Felix Need a prescription
If you are interested in learning more about whether you may be a candidate for GLP-1 medications, we invite you to take our free assessment quiz
The most recent consensus algorithm released by the ADA/EASD lists GLP-1 analogues as a treatment option for consideration as a Tier 2 agent, or less well-validated therapy, in T2DM patients ( FIGURE 1 )